Skip to content

Lawyers Collective

Professional services

UnclaimedRequest correction

Lawyers Collective is an Indian public-interest legal and human-rights organization known for advocacy involving women's rights, HIV discrimination, access to medicines, LGBT rights, tobacco control and governmental accountability.

Last updated August 25, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Lawyers Collective was an Indian non-governmental organization and public-interest legal advocacy group founded in 1981 by, among others, lawyers Indira Jaising and Anand Grover. It developed a distinctive model combining litigation, legislative advocacy, legal research, public education and support for communities facing discrimination or barriers to justice. Rather than operating as a conventional commercial law firm, the organization used legal expertise to pursue broader social and public-health objectives in India. Its work covered several interconnected areas of human rights. In the field of women's rights, Lawyers Collective supported legal reform and access to legal resources, including the 2006 “Staying Alive – Empowerment through Law” project, which was funded by a grant from the United Nations Development Fund for Women. The project was intended to help women understand and use the Indian legal system and to strengthen rights-based legal advocacy. The organization was also prominent in HIV and AIDS policy. Its HIV/AIDS unit worked on legal protections for people living with HIV and prepared a proposed HIV/AIDS bill for parliamentary consideration. The proposal addressed discrimination in employment, health care and education, as well as hostile or discriminatory propaganda. Anand Grover headed the HIV/AIDS unit and later became internationally associated with United Nations human-rights work relating to HIV. Lawyers Collective also represented the Cancer Patients Aid Association in the patent dispute Novartis v. Union of India. The case concerned Novartis's patent application for Glivec, a leukemia medicine, and raised major questions about pharmaceutical patents and access to life-saving medicines. The Supreme Court of India rejected Novartis's patent claim on 1 April 2013, and the litigation attracted international attention because of its implications for generic medicines and public-health policy. On LGBT rights, Lawyers Collective worked with the Naz Foundation and acted as its legal team in litigation challenging Section 377 of the Indian Penal Code, a provision used to criminalize consensual same-sex sexual activity. This work placed the organization within a major constitutional and human-rights debate in India, although the reference material does not specify the final procedural history of every stage of that litigation. The organization later faced significant regulatory and legal pressure. On 1 June 2016, the Government of India suspended its registration under the Foreign Contribution (Regulation) Act, 2010, alleging violations of foreign-funding rules. Lawyers Collective challenged the suspension and related action in the Bombay High Court. On 13 June 2019, the Central Bureau of Investigation registered a first information report alleging criminal conspiracy, criminal breach of trust, cheating, false statements in declarations and violations involving the FCRA and the Prevention of Corruption Act, 1988. Academics and activists characterized the proceedings as intimidation or harassment, while the allegations remained matters for legal process. The available material does not establish the organization's present operating status or the final outcome of the court and investigative proceedings.

History

Lawyers Collective emerged in India in 1981 as a collective legal initiative associated with Indira Jaising and Anand Grover. Its identity was shaped by the use of law as an instrument of social change rather than only as a private commercial service. The organization worked through court cases, proposed legislation, research, legal education and alliances with civil-society groups. A central strand of its history involved women's rights. Lawyers Collective developed legal resources intended to help women navigate the Indian legal system and participated in rights-oriented reform efforts. In 2006, it received a grant from the United Nations Development Fund for Women for “Staying Alive – Empowerment through Law,” a project focused on legal empowerment and women's rights. The initiative reflected the organization's emphasis on making legal knowledge practically useful to people facing structural inequality. Public-health law became another major area of activity. Lawyers Collective's HIV/AIDS unit worked on discrimination affecting people living with HIV and prepared a proposed bill for parliamentary debate. The draft sought protections in employment, health care and education and addressed discriminatory or hateful propaganda. Anand Grover was identified as head of this unit. The organization's work in this field connected legal advocacy with broader questions of public health, dignity and equal treatment. Lawyers Collective also became involved in the global debate over pharmaceutical patents and access to medicines. It represented the Cancer Patients Aid Association in Novartis v. Union of India, opposing Novartis's patent claim for Glivec, a medicine used in leukemia treatment. The Supreme Court of India rejected the claim on 1 April 2013. The matter was closely watched internationally because the decision affected the balance between pharmaceutical patent protection and the availability of lower-cost generic medicines. In the area of LGBT rights, Lawyers Collective worked with the Naz Foundation and served as its legal team in proceedings seeking to overturn Section 377 of the Indian Penal Code. This litigation made the organization part of one of India's most prominent constitutional disputes concerning privacy, equality and sexual orientation. The organization's later history was marked by regulatory conflict. On 1 June 2016, the Government of India suspended its registration under the Foreign Contribution (Regulation) Act, 2010, alleging non-compliance with FCRA requirements. Lawyers Collective challenged the action before the Bombay High Court. The available reference states that the case remained pending. On 13 June 2019, the Central Bureau of Investigation registered a first information report involving allegations of criminal conspiracy, criminal breach of trust, cheating, false declarations and violations under the FCRA and the Prevention of Corruption Act, 1988. Supporters, including academics and activists, described the investigation and regulatory action as intimidation or harassment. The reference material does not provide a final judicial disposition or reliable information about the organization's current operations, so its present status is recorded as unknown.

  • 2019

    CBI registers first information report

    [1]

    The Central Bureau of Investigation registers an FIR alleging multiple criminal and regulatory offenses involving the organization.

  • 2016

    FCRA registration suspended

    [1]

    The Government of India suspends the organization's foreign-contribution registration over alleged violations of FCRA requirements.

  • 2013

    Supreme Court rejects Novartis Glivec patent claim

    [1]

    The Supreme Court of India rejects Novartis's patent claim for Glivec in a case involving Lawyers Collective's representation of the Cancer Patients Aid Association.

  • 2006

    Staying Alive – Empowerment through Law project

    [1]

    A United Nations Development Fund for Women grant supports a Lawyers Collective project intended to provide legal resources and promote women's rights in India's legal system.

  • 1981

    Lawyers Collective is founded

    [1]

    The Indian legal advocacy organization is founded, with Indira Jaising and Anand Grover among its founders.

Products and positioning

A rights-based Indian legal advocacy organization using litigation, policy work and legal education to advance equality, public health, access to medicines and constitutional protections.

  • Legal advocacy

    Public-interest litigation

    Strategic court representation on issues involving constitutional rights, equality, public health, access to medicines and discrimination. The organization's litigation model sought outcomes with broader social consequences rather than serving only an individual client's private interest.

  • Public-health law

    HIV/AIDS legal advocacy

    A specialist area addressing discrimination against people living with HIV. Lawyers Collective's work included preparing a proposed HIV/AIDS bill covering employment, health care, education and discriminatory propaganda.

  • Women's rights · 2006

    Women's legal empowerment resources

    Legal information and empowerment work designed to help women use India's legal system and strengthen rights-based responses to gender inequality. The 2006 Staying Alive project is the clearest identified example.

  • Pharmaceutical and health law

    Access-to-medicines litigation

    Representation and legal advocacy concerning pharmaceutical patents and medicine availability. The best-known matter was the Novartis Glivec patent dispute, which linked Indian patent law to global access-to-medicines concerns.

  • Equality and constitutional rights

    LGBT rights litigation

    Legal representation and strategic advocacy undertaken with the Naz Foundation in litigation challenging Section 377 of the Indian Penal Code and its use against consensual same-sex relationships.

Controversies

  • 2019

    Central Bureau of Investigation FIR

    The CBI registered an FIR alleging criminal conspiracy, criminal breach of trust, cheating, false declarations and offenses under the FCRA and Prevention of Corruption Act. The reference also records criticism from academics and activists who viewed the proceedings as intimidation or harassment.

  • 2016

    Suspension of foreign-contribution registration

    The Government of India suspended Lawyers Collective's FCRA registration, alleging violations of foreign-contribution rules. The organization challenged the action in the Bombay High Court.

Read more

Marketing campaigns

  • 2006Staying Alive – Empowerment through Law

    India

    A women's-rights project supported by a United Nations Development Fund for Women grant, intended to provide legal resources and improve women's ability to use the Indian legal system.

    Outcome. The available material confirms the project's purpose but does not provide a quantified outcome.

  • HIV/AIDS anti-discrimination legislative advocacy

    India

    Lawyers Collective's HIV/AIDS unit prepared a proposed bill for parliamentary consideration that would prohibit discrimination in employment, health care and education and address discriminatory propaganda.

  • Section 377 constitutional challenge

    India

    Working with the Naz Foundation, Lawyers Collective acted as legal counsel in litigation seeking to repeal or invalidate Section 377 of the Indian Penal Code as applied to consensual same-sex conduct.

Brand decisions

  • 2016

    Challenge to FCRA suspensionOther

    Background

    The Government of India suspended the organization's foreign-contribution registration for alleged violations of FCRA norms.

    Action taken

    Lawyers Collective stated that it would contest the regulatory action and challenged it in the Bombay High Court.

    Aftermath

    The available reference describes the court matter as pending and does not establish a final resolution.

  • 2013

    Pursuit of access-to-medicines litigation in the Glivec patent caseOther

    Background

    Lawyers Collective represented the Cancer Patients Aid Association in litigation opposing Novartis's patent claim for Glivec, a leukemia medicine. The case raised questions about pharmaceutical patents and access to treatment.

    Action taken

    The organization pursued the matter through India's courts as public-interest patent and health-law litigation.

    Aftermath

    On 1 April 2013, the Supreme Court of India rejected Novartis's patent claim. The decision received international attention for its implications for generic medicines and public health.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/lawyers-collective · Editorial policy · How profiles are compiled